Konstantinos Farsalinos, MD, MPH, Greece

Dr. Farsalinos is a cardiologist and research fellow at the Onassis Cardiac Surgery Center in Athens-Greece, at the Department of Pharmacy, University of Patras-Greece and at the National School of Public Health-Greece. He is specialized in echocardiography and in smoking and tobacco harm reduction research. He has received a scholarship from the Greek Society of Cardiology and performed research on cardiovascular imaging in Catholic University of Leuven, Belgium. He was the lead researcher in Intervendor Study, a joint research project of the European and American Societies of Echocardiography.

He has been conducting laboratory, clinical and epidemiological research on smoking, tobacco harm reduction and e-cigarettes as principal investigator since 2011. Examples of his work include the first study on the cytotoxic effects of e-cigarette vapor on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation. He has analyzed patterns of e-cigarette use based on large European and US population surveys (Eurobarometer, National Youth Tobacco Survey, National Health Interview Survey, Behavioral Risk Factor Surveillance System). He also co-authored the first systematic review on e-cigarette safety, published in 2014. Additionally, he is performing research work on heated tobacco products.

His research findings have been presented in major international scientific congresses and his studies were used in preparing the regulatory framework on e-cigarettes by the European Union. As of 2019, he has published more than 70 studies and articles in international peer-reviewed scientific journals about smoking, tobacco harm reduction, and e-cigarettes. He was the handling editor and author in a book titled Analytical Assessment of E-Cigarettes, published by Elsevier in 2017.